Peking University Cancer Hospital & Institute: Neoplasm Metastasis trials

The registry lists 17 Neoplasm Metastasis studies with Peking University Cancer Hospital & Institute as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 5Phase 3 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Role and Safety of Radiofrequency Ablation in Recurrent Liver Metastasis of Colorectal CancerNot yet recruitingNCT06609434Not applicable
• Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe.Not yet recruitingNCT06435741Not applicable
• To Evaluate the Performance of HepaSphere Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy on Unresectable Colorectal Liver MetastasesNot yet recruitingNCT05889325
• Dynamic ctDNA Detection for Colorectal Cancer Liver MetastasesCompletedNCT06404593
• HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell CarcinomaCompletedNCT06184841Phase 1
• The Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver MetastasesStatus unknownNCT05877001Phase 2
• Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line TherapyStatus unknownNCT05406206Phase 2
• To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency AblationStatus unknownNCT04417010
• Study to Evaluate OrienX010 in Combination With JS001 in the Treatment of Stage IV (M1c) Liver Metastasis From MelanomaStatus unknownNCT04206358Phase 1
• Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver MetastasisCompletedNCT03031444Phase 2/3
• Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety StudyStatus unknownNCT01960829Phase 2
• Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer PatientsCompletedNCT01395056
• Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural EffusionCompletedNCT01256801
• Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer PatientsCompletedNCT01232062
• Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC)CompletedNCT01231022
• Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to ChemotherapyCompletedNCT01198301
• Xeloda Plus Paclitaxel in Gastric Cancer With Liver MetastasisStatus unknownNCT01167049Phase 2